Cardiorenal syndrome and heart failure

Current Opinion in Cardiology

Volumn 25, Issue 2, 2010, Pages 141-147

  Reinglas, Jason ^a   Haddad, Haissam ^a   Davies, Ross A ^a   Mielniczuk, Lisa ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cardiorenal syndrome; Chronic kidney disease; Heart failure; Ultrafiltration

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN RECEPTOR; FUROSEMIDE; GLYCERYL TRINITRATE; NAXIFYLLINE; NESIRITIDE; THIAZIDE DIURETIC AGENT; TOLVAPTAN;

ANEMIA; CONGESTIVE HEART FAILURE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY INJURY; LUNG CONGESTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION;

ADENOSINE; ANEMIA; CHRONIC DISEASE; DIURETICS; HEART FAILURE; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; VASODILATOR AGENTS; VASOPRESSINS;

EID: 76749142000     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328335fed7     Document Type: Review

References (39)

1. Owan TE, Hodge DO, Herges RM, et al. Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail 2006; 12:257-262.
2. Goldberg A, Hammerman H, Petcherski S, et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 2005; 150:330-337.
3. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113:671-678.
4. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006; 47:1987-1996.
5. Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008; 51 (1 Suppl 1): S1-320.
6. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16:489-495.
7. Virani SA, Khosla A, Levin A. Chronic kidney disease, heart failure and anemia. Can J Cardiol 2008; 24 (Suppl B):B22-B24.
8. Bongartz LG, Cramer MJ, Doevendans PA, et al. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 2005; 26:11-17.
9. Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 2008; 34:957-962.
10. Canadian Institute for Health Information. Canadian Organ Replacement Register and Annual Data Report; 2007.
11. Kazory A, Ross EA. Anemia: the point of convergence or divergence for kidney disease and heart failure? J Am Coll Cardiol 2009; 53:639-647.
12. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001; 37:1775-1780.
13. Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52:1527-1539.
14. Jie KE, Verhaar MC, Cramer MJ, et al. Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol 2006; 291:F932-F944.
15. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006; 47:1-8.
16. Jessup M, Costanzo MR. The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol 2009; 53:597-599.
17. McCullough PA, Sandberg KR. Chronic kidney disease and sudden death: strategies for prevention. Blood Purif 2004; 22:136-142.
18. Berl T, Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 2006; 1:8-18.
19. Mitchell JE. Emerging role of anemia in heart failure. Am J Cardiol 2007; 99 (6B):15D-20D.
20. Anand IS. Heart failure and anemia: mechanisms and pathophysiology. Heart Fail Rev 2008; 13:379-386.
21. Palazzuoli A, Gallotta M, Iovine F, et al. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anemia syndrome. Int J Clin Pract 2008; 62:281-286.
22. McClellan W, Aronoff SL, Bolton WK,et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 2004; 20:1501-1510. (Pubitemid 39361354)
23. Cunningham PN, Dyanov HM, Park P, et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002; 168:5817-5823.
24. Kumar A, Paladugu B, Mensing J, et al. Nitric oxide-dependent and -independent mechanisms are involved in TNF-alpha-induced depression of cardiac myocyte contractility. Am J Physiol Regul Integr Comp Physiol 2007; 292:R1900-R1906.
25. Liu PP. Cardiorenal syndrome in heart failure: a cardiologist's perspective. Can J Cardiol 2008; 24 (Suppl B):B25-B29.
26. Wagener G, Jan M, Kim M, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; 105:485-491.
27. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40:221-226.
28. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66:1115-1122.
29. Vande Voorde RG, Katlman TI, Ma Q. Serum NGAL and cystatin C as predictive biomarkers for acute kidney injury [abstract]. J Am Soc Nephrol 2006; 17:404A.
30. Han WK, Bailly V, Abichandani R, et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62:237-244.
31. Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 2008; 2008:135625.
32. Chen D, Assad-Kottner C, Orrego C, Torre-Amione G. Cytokines and acute heart failure. Crit Care Med 2008; 36 (1 Suppl):S9-S16.
33. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002; 8:376-388.
34. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005; 16:3046-3052.
35. Gauthier N, Anselm AH, Haddad H. New therapies in acute decompensated heart failure. Curr Opin Cardiol 2008; 23:134-140.
36. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007; 356:2064-2072.
37. Kramer BK, Schweda F, Kammerl M, Riegger GA. Diuretic therapy and diuretic resistance in cardiac failure. Nephrol Dial Transplant 1999; 14 (Suppl 4):39-42. (Pubitemid 29358865)
38. Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005:CD003178.
39. Ronco C, Ricci Z, Brendolan A, et al. Ultrafiltration in patients with hypervolemia and